Abhishek Abhishek

ORCID: 0000-0003-0121-4919
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Gout, Hyperuricemia, Uric Acid
  • Rheumatoid Arthritis Research and Therapies
  • Osteoarthritis Treatment and Mechanisms
  • Spondyloarthritis Studies and Treatments
  • Case Reports on Hematomas
  • Urticaria and Related Conditions
  • Musculoskeletal pain and rehabilitation
  • Bone and Joint Diseases
  • Autoimmune and Inflammatory Disorders Research
  • Alkaline Phosphatase Research Studies
  • Musculoskeletal synovial abnormalities and treatments
  • Systemic Lupus Erythematosus Research
  • Alcohol Consumption and Health Effects
  • Fibromyalgia and Chronic Fatigue Syndrome Research
  • Inflammatory mediators and NSAID effects
  • SARS-CoV-2 and COVID-19 Research
  • Chronic Lymphocytic Leukemia Research
  • Inflammatory Bowel Disease
  • Nail Diseases and Treatments
  • Total Knee Arthroplasty Outcomes
  • Immunodeficiency and Autoimmune Disorders
  • Liver Disease Diagnosis and Treatment
  • Venous Thromboembolism Diagnosis and Management
  • Plant Pathogens and Fungal Diseases
  • Drug-Induced Hepatotoxicity and Protection

University of Nottingham
2016-2025

Nottingham Biomedical Research Centre
2018-2025

Indian Veterinary Research Institute
2018-2025

Amrita Vishwa Vidyapeetham
2025

Indian Institute of Technology Kanpur
2025

Center for Rheumatology
2016-2024

Versus Arthritis
2013-2024

Nottingham City Hospital
2010-2024

Nottingham University Hospitals NHS Trust
2018-2024

Society for Personality and Social Psychology
2024

BackgroundIn the UK, gout management is suboptimum, with only 40% of patients receiving urate-lowering therapy, usually without titration to achieve a target serum urate concentration. Nurses successfully manage many diseases in primary care. We compared nurse-led care usual led by general practitioners (GPs) for people community.MethodsResearch nurses were trained best practice gout, including providing individualised information and engaging shared decision making. Adults who had...

10.1016/s0140-6736(18)32158-5 article EN cc-by-nc-nd The Lancet 2018-10-01

<h3>Importance</h3> Gout is associated with cardiovascular diseases. The temporal association between gout flares and events has not been investigated. <h3>Objective</h3> To investigate whether there a transient increase in risk of after recent flare. <h3>Design, Setting, Participants</h3> A retrospective observational study was conducted using electronic health records from the Clinical Practice Research Datalink England January 1, 1997, December 31, 2020. multivariable nested case-control...

10.1001/jama.2022.11390 article EN JAMA 2022-08-02

BackgroundImmunosuppressive treatments inhibit vaccine-induced immunity against SARS-CoV-2. We evaluated whether a 2-week interruption of methotrexate treatment immediately after the COVID-19 vaccine booster improved antibody responses S1 receptor-binding domain (S1-RBD) SARS-CoV-2 spike protein compared with uninterrupted in patients immune-mediated inflammatory diseases.MethodsWe did an open-label, prospective, two-arm, parallel-group, multicentre, randomised, controlled, superiority trial...

10.1016/s2213-2600(22)00186-2 article EN cc-by The Lancet Respiratory Medicine 2022-06-27

Objective Calcium pyrophosphate deposition (CPPD) disease is prevalent and has diverse presentations, but there are no validated classification criteria for this symptomatic arthritis. The American College of Rheumatology (ACR) EULAR have developed the first‐ever CPPD disease. Methods Supported by ACR EULAR, a multinational group investigators followed established methodology to develop these criteria. generated lists candidate items refined their definitions, collected de‐identified patient...

10.1002/art.42619 article EN cc-by-nc Arthritis & Rheumatology 2023-07-26

10.1016/j.rdc.2012.10.007 article EN Rheumatic Disease Clinics of North America 2013-01-11

The objectives of this study were to examine changes in the incidence and prevalence RA between 1990 2014 explore if there is any geographic variation UK.This was a primary care-based prospective cohort study. People contributing acceptable data Clinical Practice Research Datalink 1 January 31 December included. Read codes used identify cases ⩾18 years age. rates for each year standardized population regional overall population.The 3.81/10 000 person-years 0.67%, respectively, 2014. annual...

10.1093/rheumatology/kew468 article EN Lara D. Veeken 2016-11-29

<h3>Objective</h3> There is a lack of standardisation in the terminology used to describe gout. The aim this project was develop consensus statement describing recommended nomenclature for disease states <h3>Methods</h3> A content analysis gout-related articles from rheumatology and general internal medicine journals published over 5-year period identified potential labels commonly assigned them. Based on these findings, experts gout were invited participate Delphi exercise face-to-face...

10.1136/annrheumdis-2019-215933 article EN Annals of the Rheumatic Diseases 2019-09-09

<h3>Importance</h3> Osteoarthritis is a prevalent, debilitating, and costly chronic disease for which recommended first-line treatment underused. <h3>Objective</h3> To compare the effect of an internet-based knee osteoarthritis vs routine self-management (ie, usual care). <h3>Design, Setting, Participants</h3> This randomized clinical trial was conducted from October 2018 to March 2020. Participants included individuals aged 45 years or older with diagnosis recruited existing primary care...

10.1001/jamanetworkopen.2021.0012 article EN cc-by-nc-nd JAMA Network Open 2021-02-23

To estimate the incidence, prevalence, and survival of systemic sclerosis in United Kingdom. We conducted a historical cohort study using data from Clinical Practice Research Datalink (CPRD). calculated incidence between 1994 2013 examined its association with age, sex, socioeconomic status. point prevalence on 1 July same exposures. identified 1327 cases incident sclerosis. Annual was 19.4 per million person-years 2013. The 4.7 times higher women than men, not influenced by status, has...

10.1007/s10067-018-4182-3 article EN cc-by Clinical Rheumatology 2018-06-30

To develop definitions for imaging features being considered as potential classification criteria calcium pyrophosphate deposition (CPPD) disease, additional to clinical and laboratory criteria, compile example images of CPPD on different modalities.

10.1002/acr.24898 article EN Arthritis Care & Research 2022-04-19

Calcium pyrophosphate deposition (CPPD) disease is prevalent and has diverse presentations, but there are no validated classification criteria for this symptomatic arthritis. The American College of Rheumatology (ACR) EULAR have developed the first-ever CPPD disease.Supported by ACR EULAR, a multinational group investigators followed established methodology to develop these criteria. generated lists candidate items refined their definitions, collected de-identified patient profiles,...

10.1136/ard-2023-224575 article EN Annals of the Rheumatic Diseases 2023-07-26

BackgroundThe risk of significant liver fibrosis from prolonged methotrexate (MTX) exposure has been estimated in around 5% patients, which led to intensive monitoring strategies. However, the evidence is derived retrospective studies that underreported factors disease. We evaluated long-term MTX therapy on a longitudinal cohort study using two non-invasive markers.MethodBetween 2014-2021, adult patients diagnosed with Rheumatoid Arthritis (RA) or psoriasis for ≥2 years were recruited...

10.1016/j.jhep.2022.12.034 article EN cc-by Journal of Hepatology 2023-01-23
Tanya J. Major Riku Takei Hirotaka Matsuo Megan Leask Nicholas A. Sumpter and 94 more Ruth Topless Yuya Shirai Wenhua Wei Murray Cadzow Amanda Phipps‐Green Zhiqiang Li Aichang Ji Marilyn E. Merriman Emily Morice Eric E. Kelley Wenhua Wei Sally P.A. McCormick Matthew J. Bixley Richard J. Reynolds Kenneth G. Saag Tayaza Fadason Evgeniia Golovina Justin M. O’Sullivan Lisa K. Stamp Nicola Dalbeth Abhishek Abhishek Michael Doherty Edward Roddy L. Jacobsson Meliha C Kapetanovic Olle Melander Mariano Andrés Fernando Perez‐Ruiz Rosa J. Torres Timothy R. D. J. Radstake Timothy L. Jansen M. Janssen Leo A. B. Joosten Ruiqi Liu Orsolya I. Gaal Tania O. Crişan Simona Rednic Fina Kurreeman T. Huizinga René E. M. Toes Frédéric Lioté Pascal Richette Thomas Bardin Hang‐Korng Ea Tristan Pascart Géraldine McCarthy Laura Helbert Blanka Stibůrková Anne-K. Tausche Till Uhlig Véronique Vitart Thibaud Boutin Caroline Hayward Philip L. Riches Stuart H. Ralston Archie Campbell Thomas M. MacDonald Akiyoshi Nakayama Tappei Takada Masahiro Nakatochi Seiko Shimizu Yusuke Kawamura Yu Toyoda Hirofumi Nakaoka Ken Yamamoto Keitaro Matsuo Nariyoshi Shinomiya Kimiyoshi Ichida Chaeyoung Lee Linda A. Bradbury Matthew A. Brown Philip C. Robinson Russell Buchanan Catherine Hill Susan Lester Malcolm Smith Maureen Rischmueller Hyon K. Choi Eli A. Stahl Jeff N. Miner Daniel H. Solomon Jing Cui Kathleen M. Giacomini Deanna J. Brackman Eric Jorgenson Hongbo Liu Katalin Suszták Suyash Shringapure Suyash Shringarpure Alexander So Yukinori Okada Changgui Li Yongyong Shi Tony R. Merriman

10.1038/s41588-024-01921-5 article EN Nature Genetics 2024-10-15

To assess if smoking status at the time of commencing an anti-TNF-alpha agent for rheumatoid arthritis (RA) reduces likelihood achieving least a moderate response on European League Against Rheumatism (EULAR) criteria 3-month assessment.All patients with RA treated their first Department Rheumatology, Derby Hospital NHS Trust between April 2001 and October 2008 were included in this retrospective case control study. Information about age, gender, disease duration, body mass index, (current...

10.1097/rhu.0b013e3181ca4a2a article EN JCR Journal of Clinical Rheumatology 2009-12-26
Coming Soon ...